Skip to content

Outcomes of controlled transscleral cyclophotocoagulation combined with sequential lens extraction in the management of refractory acute angle closure

Outcomes of controlled transscleral cyclophotocoagulation combined with sequential lens extraction in the management of refractory acute angle closure

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900023567
Enrollment
Unknown
Registered
2019-06-02
Start date
2019-06-03
Completion date
Unknown
Last updated
2019-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute angle closure

Interventions

1:controlled transscleral cyclophotocoagulation combined with sequential lens extraction

Sponsors

Beijing Tongren Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 100 Years

Inclusion criteria

Inclusion criteria: aged >45 years; APAC patients; IOP=30mmHg under maximum drugs and/or after paracentesis or iridotomy.

Exclusion criteria

Exclusion criteria: 1)secondary glaucoma; 2)with previous anti-glaucoma surgeries or lensectomy or other intraocular surgeries (except for iridotomt); 3) combined with other ocular diseases or anomaly.

Design outcomes

Primary

MeasureTime frame
operation success rate;No. of Drugs;Degree of open agle;complications;

Countries

China

Contacts

Public ContactYan Shi

Beijing Tongren Eye Center

yansmile4433@163.com+86 18600446810

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 14, 2026